Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine Lauriad mucoadhesive buccal tablet for prevention and treatment of chemoradiotherapy-induced oral mucositis in head and neck cancer
2009-014870-16Phase 2Completed
- Sponsor
- Valerio Therapeutics
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Clonidine Lauriad in stomatitis and head and neck cancer (HNC) (3 arms), sponsored by Valerio Therapeutics. Primary endpoint: Primary efficacy comparison. Started Oct 2009; status: completed.
02
Drugs
Clonidine Lauriad
03
Conditions
stomatitishead and neck cancer (HNC)
Beyond the preview
Go deeper on 2009-014870-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014870-16.